Skip to main content

Ford Kennedy, John Josef Molenda, Alan D. Lourie

Premium
ITI Life Sciences, a Scottish entrepreneurial innovation fund, last week said that it has appointed Ford Kennedy as director of commercialization.
 
Kennedy’s role at ITI Life Sciences is to identify commercial opportunities and secure licenses for its portfolio of new technologies and intellectual property resulting from ITI research programs. Most recently, he served as director of scientific sourcing and new technologies at Millipore.
 

 
John Josef Molenda has joined Jenner & Block's New York office as of counsel in the firm's intellectual property and appellate and supreme court practices.
 
Most recently, Molenda was an associate at Frommer Lawrence & Haug LLP, where he concentrated his practice in chemical, pharmaceutical, and biotech patent litigation.
 
Molenda has a PhD in chemistry from Vanderbilt University, and conducted post-doctoral research in DNA topology at New York University. He holds a JD from the University of Michigan, and served as a judicial law clerk to the Honorable Alan D. Lourie, United States Court of Appeals for the Federal Circuit, from 1998 to 2000.
 

Molenda has litigation experience in a wide range of technologies, including drug development, genetic engineering, biochemistry, chemical compositions and material science, Jenner & Block said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.